Moncyte Health is developing a patented technology to optimize the treatment and prevention of cardiovascular disease.
Moncyte Health has raised $1.1M in total funding. The most recent round was Seed. The last funding was announced in October 2024.
Moncyte Health's investors include Inventure, Business Finland, University of Helsinki, Almaral, Athensmed.
Moncyte Health is headquartered in Helsinki, Finland.
Moncyte Health is developing a patented technology to optimize the treatment and prevention of cardiovascular disease.
Moncyte Health is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Moncyte Health — Funding & Investors." VCBacked, October 8, 2024, https://www.vcbacked.co/company/moncyte-health. Accessed October 18, 2026.
VCBacked. (2024). Moncyte Health — Funding & Investors. Retrieved October 18, 2026, from https://www.vcbacked.co/company/moncyte-health
{{cite web |title=Moncyte Health — Funding & Investors |url=https://www.vcbacked.co/company/moncyte-health |website=VCBacked |access-date=October 18, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated